Associations Between Soluble CD40 Ligand, Atherosclerosis Risk Factors, and Subclinical Atherosclerosis-Reference-Cited by-同舟云学术

Associations Between Soluble CD40 Ligand, Atherosclerosis Risk Factors, and Subclinical Atherosclerosis

Published:2005-10 Issue:10 Volume:25 Page:2192-2196
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

de Lemos James A.¹,Zirlik Andreas¹,Schönbeck Uwe¹,Varo Nerea¹,Murphy Sabina A.¹,Khera Amit¹,McGuire Darren K.¹,Stanek Greg¹,Lo Hao S.¹,Nuzzo Rebecca¹,Morrow David A.¹,Peshock Ronald¹,Libby Peter¹

Affiliation:

1. From the Donald W. Reynolds Cardiovascular Clinical Research Center (J.A.d.L., A.K., D.K.M., G.S., H.S.L., R.P.), University of Texas Southwestern Medical Center, Dallas, Tex; and the Donald W. Reynolds Cardiovascular Clinical Research Center (A.Z., U.S., N.V., S.A.M., R.N., D.A.M., P.L.), Brigham and Women’s Hospital, Boston Mass.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression.

2. Ligation of CD40 Activates Interleukin 1β-converting Enzyme (Caspase-1) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1β

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bariatric Surgery Improves Serum CD40L Levels as a Predictor of Cardiovascular Risk: Systematic Review and Meta-analysis;Obesity Surgery;2024-04-05

2. The Perspectives of Platelet Proteomics in Health and Disease;Biomedicines;2024-03-06

3. Elevated circulating inflammatory biomarker levels in the SIRT1-NF-κB-sCD40L pathway in patients with acute myocardial infarction: a case-control study;Annals of Medicine;2023-11-22

4. The relationship between the level of soluble CD40 ligand and angiographic extent and severity of coronary artery disease;Cor et Vasa;2023-06-20

5. Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention;Clinical Chemistry and Laboratory Medicine (CCLM);2021-11-01